Emergent decommissioning of HeartMate 3 for life-threatening hemorrhage

Reginald E Du1, Ryan S Bedi1, W Charles Sternbergh2,3

  • 1Section of Cardiothoracic Surgery, Department of Surgery, Ochsner Health, New Orleans, LA.

Insights

Emergent left ventricular assist device decommissioning was performed due to life-threatening hemorrhage caused by outflow graft avulsion. A covered stent and an Amplatzer II plug were used to manage the complication, highlighting potential alternative approaches for future cases.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Device Technology

Background:

  • Left ventricular assist devices (LVADs) are critical for end-stage heart failure treatment.
  • Complications such as hemorrhage can necessitate emergent device management.
  • Outflow graft avulsion from the subclavian artery is a rare but severe LVAD complication.

Observation:

  • A patient presented with life-threatening hemorrhage due to left ventricular assist device outflow graft avulsion from the left subclavian artery.
  • The emergent procedure involved using a covered stent to exclude the avulsed graft and an Amplatzer II plug to occlude the inflow cannula.
  • Accessing the inflow cannula presented significant technical challenges during the procedure.

Findings:

  • Successful management of life-threatening hemorrhage secondary to LVAD outflow graft avulsion was achieved using a combination of a covered stent and an occlusion device.
  • The technical difficulties encountered underscore the complexity of managing emergent LVAD-related vascular complications.
  • Retrospective analysis suggests that preemptive occlusion of the outflow graft via the subclavian artery prior to stent deployment could offer a simplified approach.

Implications:

  • This case demonstrates a viable strategy for managing severe LVAD outflow graft avulsion, offering a potential alternative to explantation.
  • The findings highlight the importance of considering anatomical access and potential complications when planning LVAD interventions.
  • Improved techniques for managing emergent LVAD complications could enhance patient outcomes and reduce procedural risks.

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...